Carboxy X rhodamine analogs

US10139400B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10139400-B2
Application numberUS-201514724111-A
CountryUS
Kind codeB2
Filing dateMay 28, 2015
Priority dateNov 21, 2011
Publication dateNov 27, 2018
Grant dateNov 27, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides novel fluorescent dyes and kits containing the same, which are useful for labeling a wide variety of biomolecules, cells and microorganisms. The present invention also provides various methods of using the fluorescent dyes for research and development, forensic identification, environmental studies, diagnosis, prognosis and/or treatment of disease conditions.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method to detect a selected molecule in a sample, comprising: a) contacting a sample suspected of containing the selected molecule with a composition comprising a dye conjugate according to formula (IIIa), (IIIb) or (IIIc) so as to yield a mixture: wherein R 11 is independently H or C 1-4 alkyl or L-C s ; L is a covalent linkage that is linear or branched, cyclic or heterocyclic saturated or unsaturated, having 1-16 non hydrogen atoms such that the linkage contains any combination of ester, acid, amine, amide, alcohol, ether, thioether or halide groups or single, double, triple or aromatic carbon-carbon bond; C s is a conjugated substance selected from the group consisting of solid supports, resin particles, beads, assay plates, proteins, nucleotides, polynucleotides, enzyme substrates, nanobodies, polypeptides, amino acids, lipids, carbohydrates, haptens, drugs, ion-complexing agents, microparticles, polymers, cells, viruses, fluorophores, chloroalkanes, and cyanobenzothiazoles; R 2 and R 16 can be independently H, alkyl, aryl, heteroaryl, CO 2 H, SO 3 H, L-CO 2 H, L-SO 3 H, or L-C s ; R 3 and R 4 are H, alkyl, L-C s , L-CO 2 H, L-SO 3 H or together form a carbocyclic, aryl, heteroaryl, or heterocyclic ring; alternatively, R 2 and R 3 and independently R 4 and R 16 together form a carbocyclic, heterocyclic, aryl or heteroaryl ring; R 5 , R 12 , R 13 , R 14 and R 15 are independently H, alkyl, aryl, heteroaryl, CO 2 H, SO 3 H, L-CO 2 H, L-SO 3 H, or L-C s ; R 20 , R 21 , R 22 and R 23 are independently H or C 1-6 alkyl or one or more of R 20 and R 21 , R 21 and R 22 , R 22 and R 23 , together form an aryl, heteroaryl, carbocyclic or heterocyclic ring; alternatively R 11 and R 12 together form a carbocyclic, heterocyclic, aryl or heteroaryl ring; R 6-10 are independently H, F, Cl, Br, I, OH, alkyl, aryl, heteroaryl, CO 2 H, SO 3 H, L-CO 2 H, L-SO 3 H, or L-C s ; X is CHR 23 , O, S or NR 30 ; and R 30 is H, C1-4 alkyl or —C(O)C1-4 alkyl; and b) detecting the presence or amount of the dye conjugate in the mixture, thereby detecting the selected molecule in the sample. 2. The method of claim 1 , wherein at least one of R 2-16 is -L-C s . 3. The method of claim 1 , wherein C s is a polynucleotide. 4. A method of detecting the presence of a nucleic acid polymer in a sample comprising: a) contacting a sample suspected of containing a nucleic acid polymer with a composition comprising a dye conjugate according to formula (IIIa), (IIIb) or (IIIc) so as to yield a mixture: wherein R 11 is independently H, C 1-4 alkyl, or L-C s ; L is a covalent linkage that is linear or branched, cyclic or heterocyclic saturated or unsaturated, having 1-16 non hydrogen atoms such that the linkage contains any combination of ester, acid, amine, amide, alcohol, ether, thioether or halide groups or single, double, triple or aromatic carbon-carbon bond; C s is an oligonucleotide; R 2 and R 16 can be independently H, alkyl, aryl, heteroaryl, CO 2 H, SO 3 H, L-CO 2 H, L-SO 3 H, or L-C s ; R 3 and R 4 are H, alkyl, L-C s , L-CO 2 H, L-SO 3 H or together form a carbocyclic, aryl, heteroaryl, or heterocyclic ring; alternatively, R 2 and R 3 and independently R 4 and R 16 together form a carbocyclic, heterocyclic, aryl or heteroaryl ring; R 5 , R 12 , R 13 , R 14 and R 15 are independently H, alkyl, aryl, heteroaryl, CO 2 H, SO 3 H, L-CO 2 H, L-SO 3 H, or L-C s ; R 20 , R 21 , R 22 and R 23 are independently H or C 1-6 alkyl or one or more of R 20 and R 21 , R 21 and R 22 , R 22 and R 23 , together form an aryl, heteroaryl, carbocyclic or heterocyclic ring; alternatively, R 11 and R 12 together form a carbocyclic, heterocyclic, aryl or heteroaryl ring; R 6-10 are independently H, F, Cl, Br, I, OH, alkyl, aryl, heteroaryl, CO 2 H, SO 3 H, L-CO 2 H, L-SO 3 H, or L-C s ; X is CHR 23 , O, S or NR 30 ; and R 30 is H, C 1-4 alkyl or —C(O)C 1-4 alkyl; and b) detecting the presence or amount of the dye conjugate in the mixture, thereby detecting the presence of the nucleic acid polymer in the sample. 5. The method of claim 4 , wherein more than one nucleic acid polymer in a sample is detected in a single reaction. 6. The method of claim 5 , wherein the more than one nucleic acid polymer is detected by capillary electrophoresis. 7. A method of labeling a biomolecule comprising: a) contacting a sample suspected of containing the biomolecule with a composition comprising a dye conjugate according to formula (IIIa), (IIIb) or (IIIc) so as to yield a mixture: wherein R 11 is independently H or C 1-4 alkyl, or L-C s ; L is a covalent linkage that is linear or branched, cyclic or heterocyclic saturated or unsaturated, having 1-16 non hydrogen atoms such that the linkage contains any combination of ester, acid, amine, amide, alcohol, ether, thioether or halide groups or single, double, triple or aromatic carbon-carbon bond; C s is a conjugated substance selected from the group consisting of solid supports, resin particles, beads, assay plates, proteins, nucleotides, polynucleotides, enzyme substrates, nanobodies, polypeptides, amino acids, lipids, carbohydrates, haptens, drugs, ion-complexing agents, microparticles, polymers, cells, viruses, fluorophores, chloroalkanes, and cyanobenzothiazoles; R 2 and R 16 can be independently H, alkyl, aryl, heteroaryl, CO 2 H, SO 3 H, L-CO 2 H, L-SO 3 H, or L-C s ; R 3 and R 4 are H, alkyl, L-C s , L-CO 2 H, L-SO 3 H or together form a carbocyclic, aryl, heteroaryl, or heterocyclic ring; alternatively, R 2 and R 3 and independently R 4 and R 16 together form a carbocyclic, heterocyclic, aryl or heteroaryl ring; R 5 , R 12 , R 13 , R 14 and R 15 are independently H, alkyl, aryl, heteroaryl, CO 2 H, SO 3 H, L-CO 2 H, L-SO 3 H, or L-C s ; R 20 , R 21 , R 22 and R 23 are independently H or C 1-6 alkyl or one or more of R 20 and R 21 , R 21 and R 22 , R 22 and R 23 , together form an aryl, heteroaryl, carbocyclic or heterocyclic ring; alternatively R 11 and R 12 together form a carbocyclic, heterocyclic, aryl or heteroaryl ring; R 6-10 are independently H, F, Cl, Br, I, OH, alkyl, aryl, heteroaryl, CO 2 H, SO 3 H, L-CO 2 H, L-SO 3 H, or L-C s ; X is CHR 23 , O, S or NR 30 ; and R 30 is H, C 1-4 alkyl or —C(O)C 1-4 alkyl; b) detecting the presence or amount of the dye conjugate, thereby detecting the presence or amount of the labeled biomolecule in the mixture. 8. The method of claim 7 , wherein the dye conjugate contains a cyanobenzothiazole. 9. The method of claim 7 , wherein the biomolecule is a protein. 10. The method of claim 9 , wherein the protein comprises an N-terminal cysteine. 11. The method of claim 10 , wherein the protein comprising an N-terminal cysteine is labeled with the dye conjugate comprising a cyanobenzothiazole. 12. The method of claim 4 , wherein L is —CO—, —SCH 2 CO—, or —SO 2 —. 13. The method of claim 12 , wherein L is —SCH 2 CO— and L is bonded to a nucleotide base in the oligonucleotide to form a group

Assignees

Inventors

Classifications

  • Polymerase chain reaction [PCR] · CPC title

  • with fluorescent label · CPC title

  • at least one of the hetero rings does not contain nitrogen as ring hetero atom · CPC title

  • G01N33/542Primary

    with steric inhibition or signal modification, e.g. fluorescent quenching · CPC title

  • Peri-condensed systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10139400B2 cover?
The present invention provides novel fluorescent dyes and kits containing the same, which are useful for labeling a wide variety of biomolecules, cells and microorganisms. The present invention also provides various methods of using the fluorescent dyes for research and development, forensic identification, environmental studies, diagnosis, prognosis and/or treatment of disease conditions.
Who is the assignee on this patent?
Promega Corp
What technology area does this patent fall under?
Primary CPC classification G01N33/542. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).